Celldex Therapeutics reported $-14224000 in Pre-Tax Profit for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbvie ABBV:US $ 5913M 192M
Agenus AGEN:US $ -51.65M 3.4M
Amgen AMGN:US $ 2634M 338M
Aptinyx Inc APTX:US $ -11338000 10.09M
Biocept BIOC:US $ -4.88M 1.61M
Bristol Myers Squibb BMY:US $ 3941M 572M
Celldex Therapeutics CLDX:US $ -14.22M 2.96M
Glaxosmithkline GSK:US $ 2085.11M 1115.75M
Immunogen IMGN:US $ 31.39M 53.76M
Pfizer PFE:US $ 2665M 2020M
Rigel Pharmaceuticals RIGL:US $ -14.17M 3.4M
Seattle Genetics SGEN:US $ 165.88M 473.52M